REG-LocoSoco Group Plc: LocoSoco UK Distributor for Silo Wellness Mushrooms

LocoSocoAnnouncement

06/08/2021 07:25

LocoSoco Group Plc

("LocoSoco", or "the Company")

Silo Wellness Brings Marley One Mushrooms to the U.K. Market through 
 Distribution Agreement with LocoSoco.

Thursday 5(th)August  2021

LocoSoco Group Plc  (“LocoSoco”, “LOCO”), the company that builds
technology to profit from creating sustainable communities and is listed on
the Direct Market segment of the Vienna MTF, is pleased to announce a new
distribution agreement with Silo Wellness Inc. (“Silo Wellness”) (CSE:
SILO) (OTCQB: SILFF) (FRA: 3K70). 

LocoSoco is listed on the Direct Market segment of the Vienna MTF. For quotes
and trading data, link
here: https://www.wienerborse.at/en/market-data/shares-others/quote-direct/?ISIN=GB00BD5BTL23&ID_NOTATION=246035708

Silo Wellness Agreement

LocoSoco Group Plc today announces a nationwide distribution partnership with
Silo Wellness Inc, a leading global psychedelics company, pursuant to a
distribution agreement dated August 4, 2021 (the “Distribution
Agreement”). The Distribution Agreement stipulates LocoSoco as the exclusive
U.K. distributor for Silo Wellness’ full portfolio of Marley One branded
mushroom products.

This partnership announcement comes on the heels of Silo Wellness’ launch of
Marley One, the first global functional and psychedelic mushroom consumer
brand, created in collaboration with the family of legendary musician Bob
Marley. The Distribution Agreement cements a solid route to market for Marley
One products that can keep pace with consumer demand across the region. Silo
Wellness is also the first global psychedelics company to access the
nationwide network of a large-scale distributor to reach consumers across the
U.K. at mainstream retail stores. 

“Since the launch of Marley One, we’ve been vetting potential partners to
help us bring the powerful health and wellness benefits of functional
mushrooms to the U.K., where consumer interest in these products is on the
rise, and psychedelic products as regulations allows,”said Douglas K.
Gordon, Chief Executive Officer, Silo Wellness. “In LocoSoco, we’ve found
a uniquely structured distribution network and like-minded collaborator who
shares not only our dynamic vision for the mushroom category but also our
principles around community building and value sharing at every point in the
supply chain. We think the industry at large will benefit from the synergies
of these two established, publicly-traded companies working in sync.” 

LocoSoco will distribute the full line of Marley One mushroom products,
beginning with the brand’s initial five functional mushroom tinctures, to
independent retailers, buying groups, health food stores, online retailers and
influencers and their e-commerce affiliates, across the United Kingdom. The
exclusive distribution by LocoSoco is based on a minimum commitment of orders
with a value of US $1.4M of Marley One products. The Agreement reflects
consumer demand for mushroom-based wellness products and the market potential
for functional mushrooms in particular, which constituted aGBP £18,409
million, or US$ 25,415 million market globally, in 2020,according to Mordor
Intelligence
(https://www.researchandmarkets.com/reports/5318191/functional-mushroom-market-growth-trends?utm_source=BW&utm_medium=PressRelease&utm_code=lwrv67&utm_campaign=1538139+-+Global+Functional+Mushroom+Market+(2021+to+2026)+-+Growth%2c+Trends%2c+COVID-19+Impact).
The global psychedelic drugs market at large is projected to reach US$6.85
billion by 2027, growing at a CAGR of 16.3% over the next eight years,
according to Data Bridge Market Research
(https://www.prnewswire.com/news-releases/psychedelic-drugs-market-size-is-projected-to-reach-10-75-billion-by-2027--301273405.html). 

The initial portfolio of Marley One mushroom products is a range of functional
mushroom tinctures with unique blends highlighting the brand’s connection to
Jamaica.  Marley One mushroom tinctures include species such as cordyceps,
lion's mane, chaga, reishi and turkey tail that offer a range of distinct
health and wellness benefits, from improved immunity and gut health to
cognitive function and sleep enhancement. The Company intends to launch a
psychedelic mushroom product line under the Marley name later this year, to be
followed by additional functional mushroom products including gummies,
capsules and cosmetics. LocoSoco will be the sole distributor of Marley
products across the U.K. 

"We are thrilled to align with Silo Wellness, a company catalyzing growth in
the burgeoning functional mushroom industry, to build a strategic route to
market for their iconic Marley One product portfolio,”said LocoSoco CEO
James Perry. "We are extremely selective with who we choose to partner with,
and we’re proud to leverage our unique network of local and independent
retailers to support a future-thinking, sustainable and ethical brand like
Marley One in gaining access to consumers and communities across the U.K.” 

For more information about Silo Wellness, please
visit https://www.silowellness.com/. To buy Marley One products outside of
the U.K., please visit https://marleyone.com/and
visit https://locoso.co/marley-onefor U.K. sales

Ends.

Enquiries:

LocoSoco Group PLC

James Perry, Chief Executive Officer

Simon Rendell, Non-Executive Chairman

+44 (0)203 538 0716

locosoco@locoso.co

Novus Communications Ltd

Alan Green / Jacqueline Briscoe

+44 (0)7976 431608 / +44 (0)207 448 9839

Keswick Global AG - Capital Market Coach

Tim Curle, Klaus Schwerdtfeger

info@keswickglobal.com / +43 (1)740 408045

About LocoSoco Group Plc

LocoSoco builds technology to profit from creating sustainable communities. We
work with community partners to turn community assets into eco-enterprises
enabling them to generate additional revenues whilst going green.

Community partners have the opportunity to engage with their local community
on sustainability, whilst also earning additional revenue for themselves,
their businesses and causes.

LocoSoco Group Plc listed on the Austrian Wiener Borse Direkt Market in
February 2019.

About Silo Wellness Inc.

Silo Wellness is a growth-oriented holding company focused on functional
mushroom and psychedelic opportunities that benefit from a unified ecosystem
and exceptional leadership. Founded in 2018 and headquartered in Toronto, Silo
Wellness has operations in Jamaica and Oregon. Silo Wellness is a
publicly-traded company on the Canadian (CSE: SILO) and Frankfurt (FRA: CK70)
exchanges and trading on the OTCQB Venture Market (OTCQB: SILFF).

Silo Wellness offers a diverse and growing portfolio of functional mushroom
products, psychedelic wellness retreats in Jamaica and Oregon, cultivation of
psychedelic mushrooms and truffles in Jamaica, development of a
brick-and-mortar smart shop in Jamaica, and intellectual property, focused
initially on the commercialization of its metered-dosing psilocybin nasal
spray. 

In March 2021, Silo Wellness announced a multi-year licensing agreement with
the family of legendary musician Bob Marley for the exclusive worldwide rights
to brand, market and sell a distinct product line of functional and
psychedelic mushrooms. The Marley One line of functional mushrooms is
available at www.marley.one.  

For more information about Silo Wellness, please
visit www.silowellness.com. 



Copyright (c) 2021 PR Newswire Association,LLC. All Rights Reserved